Overall survival results from the randomized phase 2 study of palbociclib in combination with letrozole versus letrozole alone for first-line treatment of ER+/HER2- advanced breast cancer (PALOMA-1, TRIO-18).
Saved in:
| Title: | Overall survival results from the randomized phase 2 study of palbociclib in combination with letrozole versus letrozole alone for first-line treatment of ER+/HER2- advanced breast cancer (PALOMA-1, TRIO-18). |
|---|---|
| Authors: | Finn RS; David Geffen School of Medicine, University of California Los Angeles, 2825 Santa Monica Blvd, Suite 200, Santa Monica, CA, USA. RFinn@mednet.ucla.edu., Boer K; Onkologia, Szent Margit Korhaz, Budapest, Hungary., Bondarenko I; Dnipropetrovsk State Medical Academy, Dnipropetrovsk, Ukraine., Patel R; Comprehensive Blood and Cancer Center, Bakersfield, CA, USA., Pinter T; Petz Aladar Megyei Oktato Korhaz, Gyor, Hungary., Schmidt M; Department of Obstetrics and Gynecology, University Medical Center Mainz, Mainz, Germany., Shparyk YV; Lviv State Oncologic Regional Treatment and Diagnostic Center, Lviv, Ukraine., Thummala A; Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA., Voitko N; Kyiv City Clinical Oncology Center, Kyiv, Ukraine., Bananis E; Pfizer Inc, New York, NY, USA., McRoy L; Pfizer Inc, New York, NY, USA., Wilner K; Pfizer Inc, San Diego, CA, USA., Huang X; Pfizer Inc, San Diego, CA, USA., Kim S; Pfizer Inc, San Diego, CA, USA., Slamon DJ; David Geffen School of Medicine, University of California Los Angeles, 2825 Santa Monica Blvd, Suite 200, Santa Monica, CA, USA., Ettl J; Department of Obstetrics and Gynecology, Klinikum Rechts Der Isar, Technische Universität München, München, Germany. |
| Source: | Breast cancer research and treatment [Breast Cancer Res Treat] 2020 Sep; Vol. 183 (2), pp. 419-428. Date of Electronic Publication: 2020 Jul 18. |
| Publication Type: | Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial |
| Journal Info: | Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1573-7217 |
|---|---|
| DOI: | 10.1007/s10549-020-05755-7 |
